HEALTHBEACON TO PRESENT ON THEIR U.S. EXPANSION FOR THEIR FDA CLEARED ADHERENCE TECH FOR INJECTABLE MEDICATION DURING THE 37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
[Boston, MA., Jan. 10 2020] – HealthBeacon, a medication adherence technology company that develops smart tools for managing medication, today announced that Jim Joyce, CEO and Co-Founder, will present at the Digital Medicine & Medtech Showcase™ in San Francisco on Tuesday, January 14th at 11:00 am Pacific time.
Jim Joyce, CEO will be announcing HealthBeacon’s US expansion for their FDA cleared adherence technology for injectable medication at Digital Medicine & Medtech Showcase as follows:
Date: Tuesday, January 14, 2020
Time: 11AM (PST)
Room: Balboa (Level 4)
Venue: Parc 55 – A Hilton Hotel, 55 Cyril Magnin Street, San Francisco, CA (United States)
Jim Joyce
Jim Joyce, CEO of HealthBeacon,has an MBA from University College of Dublin and BA in Economics from Fordham University. He is the CEO and Co-Founder of HealthBeacon, a Dublin, Ireland based medical adherence technology company.
ABOUT HEALTHBEACON
HealthBeacon is a medication adherence technology company which develops smart tools for managing medication at home. HealthBeacon’s FDA cleared smart sharps bin tracks patient injection history, provides personalized interactive reminders and safely stores used injectables. With the intervention of HealthBeacon’s Smart Sharps Technology, patients’ persistence and adherence increased by 25-30% within twelve months of initiating therapy. The HealthBeacon integrated model connects a patient’s routine and the prescribing clinician’s workflow. This technology has been adopted across thirteen countries with >300,000 injections tracked since launch in 2014, with a patient acceptance rate of 80-90%. For more information, visit: www.healthbeacon.com or engage with HealthBeacon on LinkedIn or Twitter.
Media Contact:
Mary Principe | comms@healthbeacon.com